Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
Details for Australian Patent Application No. 2005212409 (hide)
International Classifications
Event Publications
24 August 2006 PCT application entered the National Phase
PCT publication WO2005/077954 Priority application(s): WO2005/077954
13 September 2007 Change of Name(s) of Applicant(s), Section 104
Schering Corporation; Pharmacopeia Drug Discovery, Inc. The name of the applicant has been changed to Schering Corporation; Pharmacopeia, Inc.
1 December 2011 Application Accepted
Published as AU-B-2005212409
29 March 2012 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 29 Feb 2012. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
19 July 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 29 Feb 2012
26 July 2012 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Pharmacopeia, Inc. and Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005212414-Packages with active agents
2005212405-Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser